Adverse events of biomedicines [electronic resource] : prevention through understanding / Giuseppe Tridente.
2014
RM302.5 .T75 2014a
Formats
| Format | |
|---|---|
| BibTeX | |
| MARCXML | |
| TextMARC | |
| MARC | |
| DublinCore | |
| EndNote | |
| NLM | |
| RefWorks | |
| RIS |
Cite
Citation
Linked e-resources
Linked Resource
Details
Title
Adverse events of biomedicines [electronic resource] : prevention through understanding / Giuseppe Tridente.
Author
ISBN
9788847053137 electronic book
8847053137 electronic book
9788847053120
8847053137 electronic book
9788847053120
Published
Verona : Springer, [2014]
Copyright
©2014
Language
English
Description
1 online resource (xxx, 633 pages)
Item Number
10.1007/978-88-470-5313-7 doi
Call Number
RM302.5 .T75 2014a
Dewey Decimal Classification
615.7042
Summary
This monograph gathers and evaluates data on adverse events (AEs) associated specifically with those biomedicines monoclonal antibodies, fusion proteins, and cytokines that have recently entered therapeutic use in humans. All AEs observed when using each member of this new drug class are covered, with a view to improving understanding of pathogenesis, facilitating prevention, monitoring, and control, and contributing to the development of better drugs that provide benefits while minimizing risk. Further aspects here examined include the role of drug mechanisms of action and immunogenicity in relation to AEs outcome and induction of systemic syndromes. Additional data on AEs in off-label treatments are also considered. Electronic data sheets, downloadable from the Springer Extra Materials platform, include more detailed safety data as well as additional basic information on product characteristics, pre- and post-marketing AEs classified according to frequency, and system/organ targeting. Data on excipients and selected information on drug interactions and associations are also provided. Adverse Events with Biomedicines: Prevention Through Understanding will serve as a detailed, practical guideline to this important new area, which demands the attention of clinicians, immunologists, oncologists, allergologists, public health professionals, and drug companies.
Bibliography, etc. Note
Includes bibliographical references.
Access Note
Access limited to authorized users.
Source of Description
Description based on print version record.
Available in Other Form
Linked Resources
Record Appears in
Table of Contents
General Aspects
Monoclonal antibodies
Fusion proteins
Overview.
Monoclonal antibodies
Fusion proteins
Overview.